Page 725 - Williams Hematology ( PDFDrive )
P. 725

700            Part VI:  The Erythrocyte                                                                                                                                     Chapter 47:  Erythrocyte Enzyme Disorders             701





                TABLE 47–2.  Red Cell Enzyme Abnormalities Leading to Hemolytic Disease
                                                                           Diagnosis (Reference)
                                                           Red Cell                             Response to   Approximate
                Enzyme       Clinical Features  Inheritance  Morphology  Screening Test  Assay  Splenectomy *  Frequency †
                Hexokinase   HNSHA            AR           Unremarkable  —            580       + +          Rare
                Glucose      HNSHA; neurologic   AR        Unremarkable  580          580       + + +        Unusual
                phosphate    abnormalities
                isomerase
                Phosphofruc-  HNSHA and/or    AR           Unremarkable  —            580       0            Rare
                tokinase     muscle glycogen
                             storage disease
                Aldolase     HNSHA and mild   AR           Unremarkable  —            580       ?            Very rare
                             liver glycogen
                             storage; myopathy,
                             mental retardation
                Triose-      HNSHA and severe   AR         Unremarkable  580          580       ?            Rare
                phosphate    neuromuscular
                isomerase    disease
                Phosphoglyc-  HNSHA; myoglobi-  SL         Unremarkable  —            580       + +          Rare
                erate kinase  nuria neuromuscu-
                             lar disorder
                Pyruvate     HNSHA            AR           Usually unre-  580         580       + +          Unusual
                kinase                                     markable;
                                                           occasionally
                                                           contracted
                                                           echinocytes
                Glucose-6-   HNSHA; drug- or   SL          Usually unre-  580         580       ±            Very common
                phosphate    infection-induced             markable;
                dehydrogenase hemolysis; favism            rarely "bite
                                                           cells"
                Glutathione   Drug-sensitive   AR          Unremarkable  580          580       ?            Very rare
                reductase    hemolytic anemia
                             and favism
                Glutamate    HNSHA; drug- or   AR          Unremarkable  644          645       ?            Very rare
                cysteine     infection-induced
                synthetase   hemolysis; neuro-
                             logic abnormalities
                Glutathione   HNSHA; drug- or   AR         Usually      644           645       0            Rare
                synthetase   infection-induced             unremarkable
                             hemolysis; neuro-
                             logic defect and
                             5-oxoprolinuria in
                             some cases
                Pyrimidine   HNSHA; mental    AR           Prominent    646           647       0            Unusual
                5′-nucleotidase retardation in some        stippling
                             cases
                Adenylate    HNSHA            AR           Unremarkable  —            580       ?            Rare
                kinase
                Adenosine    HNSHA            AD           Unremarkable  —            580       ?            Very rare
                deaminase
                (increased
                activity)

               AD, autosomal dominant; AR, autosomal recessive; HNSHA, hereditary nonspherocytic hemolytic anemia; SL, sex-linked; —, not applicable.
               *On a scale of 0 to 4+, where 4+ is a complete response. In many cases, data are meager.
               † Very common if incidence is >5 percent. Unusual if >100 cases reported. Rare if 10 to 100 cases reported. Very rare if <10 cases reported.
               ‡ Recent reports.









          Kaushansky_chapter 47_p0689-0724.indd   700                                                                   9/17/15   6:44 PM
   720   721   722   723   724   725   726   727   728   729   730